Albany, CA, United States of America

Jian Luo

USPTO Granted Patents = 32 

 

 

Average Co-Inventor Count = 2.4

ph-index = 15

Forward Citations = 450(Granted Patents)


Location History:

  • Brisbane, CA (US) (1997 - 2013)
  • Yorba Lina, CA (US) (2019)
  • Albany, CA (US) (2011 - 2023)

Company Filing History:


Years Active: 1997-2023

Loading Chart...
Loading Chart...
Loading Chart...
32 patents (USPTO):

Title: Jian Luo: Innovator in Biotechnology and Pharmacology

Introduction

Jian Luo, based in Albany, CA, is a prolific inventor with a remarkable portfolio of 26 patents. His contributions primarily focus on biopharmaceutical innovations, particularly in the treatment of liver and bile acid-related disorders. With a keen interest in advances that leverage specific polypeptide variants, Jian Luo's work is at the forefront of biotechnology.

Latest Patents

Among his most recent inventions are methods for utilizing variants of fibroblast growth factor 19 (FGF19) polypeptides for treating primary biliary cirrhosis. This pioneering work outlines innovative methods to address a challenging liver condition effectively. Additionally, he has developed methods for predicting clinical sensitivity to treatments of bile acid-related disorders. This invention harnesses the potential of 7α-hydroxy-4-cholesten-3-one (C4) as a biomarker, aiding in the precision treatment of disorders linked to bile acids through the use of specific peptide sequences and variants.

Career Highlights

Throughout his career, Jian Luo has been associated with notable companies such as Ngm Biopharmaceuticals, Inc. His work there has significantly influenced the biotechnology sector, driving forward the development of novel therapeutic solutions.

Collaborations

Jian has collaborated with leading professionals in the field, including Lei Ling and Kenneth L Luskey. These collaborations have further strengthened the innovative impact of his research and patent applications.

Conclusion

Jian Luo's inventive expertise in biotechnology showcases the potential of leveraging specific polypeptide variants in therapeutic applications. His continued focus on innovations in the treatment of liver-related disorders positions him as a key figure in the realm of biopharmaceutical research. As he develops further patents, the biotech community eagerly anticipates the advancements that will emerge from his work.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…